22/05/2026
Counterfeit pharmaceuticals remain one of the most serious brand protection and public health challenges in the Nigerian market.
In Nigeria, pharmaceutical brand protection typically involves three coordinated layers. NAFDAC's market surveillance and post-market monitoring operations provide regulatory authority to act against substandard and counterfeit medicines. The Nigerian Customs Service IPR unit monitors border entry points for infringing imports. And where criminal conduct is established, prosecution through the appropriate courts may follow civil enforcement actions.
Navigating this model requires direct working relationships with officials at each agency — not merely an understanding of the statutory framework.
Contact us at [email protected]